These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24905461)

  • 1. Testicular differentiation factor SF-1 is required for human spleen development.
    Zangen D; Kaufman Y; Banne E; Weinberg-Shukron A; Abulibdeh A; Garfinkel BP; Dweik D; Kanaan M; Camats N; Flück C; Renbaum P; Levy-Lahad E
    J Clin Invest; 2014 May; 124(5):2071-5. PubMed ID: 24905461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess DAX1 leads to XY ovotesticular disorder of sex development (DSD) in mice by inhibiting steroidogenic factor-1 (SF1) activation of the testis enhancer of SRY-box-9 (Sox9).
    Ludbrook LM; Bernard P; Bagheri-Fam S; Ryan J; Sekido R; Wilhelm D; Lovell-Badge R; Harley VR
    Endocrinology; 2012 Apr; 153(4):1948-58. PubMed ID: 22294746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of SOX9 regulation in 46XY disorders of sex development with SRY, SOX9 and SF1 mutations.
    Knower KC; Kelly S; Ludbrook LM; Bagheri-Fam S; Sim H; Bernard P; Sekido R; Lovell-Badge R; Harley VR
    PLoS One; 2011 Mar; 6(3):e17751. PubMed ID: 21412441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function.
    Lin L; Philibert P; Ferraz-de-Souza B; Kelberman D; Homfray T; Albanese A; Molini V; Sebire NJ; Einaudi S; Conway GS; Hughes IA; Jameson JL; Sultan C; Dattani MT; Achermann JC
    J Clin Endocrinol Metab; 2007 Mar; 92(3):991-9. PubMed ID: 17200175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer.
    Sekido R; Lovell-Badge R
    Nature; 2008 Jun; 453(7197):930-4. PubMed ID: 18454134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant NR5A1/SF-1 in patients with disorders of sex development shows defective activation of the SOX9 TESCO enhancer.
    Sreenivasan R; Ludbrook L; Fisher B; Declosmenil F; Knower KC; Croft B; Bird AD; Ryan J; Bashamboo A; Sinclair AH; Koopman P; McElreavey K; Poulat F; Harley VR
    Hum Mutat; 2018 Dec; 39(12):1861-1874. PubMed ID: 30067310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the gene coding for steroidogenic factor 1 (SF1, NR5A1) in a cohort of 50 Egyptian patients with 46,XY disorders of sex development.
    Tantawy S; Mazen I; Soliman H; Anwar G; Atef A; El-Gammal M; El-Kotoury A; Mekkawy M; Torky A; Rudolf A; Schrumpf P; Grüters A; Krude H; Dumargne MC; Astudillo R; Bashamboo A; Biebermann H; Köhler B
    Eur J Endocrinol; 2014 May; 170(5):759-67. PubMed ID: 24591553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt signaling in ovarian development inhibits Sf1 activation of Sox9 via the Tesco enhancer.
    Bernard P; Ryan J; Sim H; Czech DP; Sinclair AH; Koopman P; Harley VR
    Endocrinology; 2012 Feb; 153(2):901-12. PubMed ID: 22128028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the testis-specific enhancer of SOX9 in the SRY independent sex-determining mechanism in the genus Tokudaia.
    Kimura R; Murata C; Kuroki Y; Kuroiwa A
    PLoS One; 2014; 9(9):e108779. PubMed ID: 25265165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SF1 and spleen development: new heterozygous mutation, literature review and consequences for NR5A1-mutated patient's management.
    Colson C; Aubry E; Cartigny M; Rémy AA; Franquet H; Leroy X; Kéchid G; Lefèvre C; Besson R; Cools M; Spinoit AF; Sultan C; Manouvrier S; Philibert P; Ghoumid J
    Clin Genet; 2017 Jul; 92(1):99-103. PubMed ID: 28032338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a New Enhancer That Promotes Sox9 Expression by a Comparative Analysis of Mouse and Sry-Deficient Amami Spiny Rat.
    Hirata Y; Mizushima S; Mitsukawa S; Kon M; Kuroki Y; Jogahara T; Shinohara N; Kuroiwa A
    Cytogenet Genome Res; 2023; 163(5-6):307-316. PubMed ID: 38246151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update--steroidogenic factor 1 (SF-1, NR5A1).
    Köhler B; Achermann JC
    Minerva Endocrinol; 2010 Jun; 35(2):73-86. PubMed ID: 20595937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex reversal in C57BL/6J XY mice caused by increased expression of ovarian genes and insufficient activation of the testis determining pathway.
    Correa SM; Washburn LL; Kahlon RS; Musson MC; Bouma GJ; Eicher EM; Albrecht KH
    PLoS Genet; 2012; 8(4):e1002569. PubMed ID: 22496664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroidogenic factor-1 (SF-1) gene mutation as a frequent cause of primary amenorrhea in 46,XY female adolescents with low testosterone concentration.
    Philibert P; Leprieur E; Zenaty D; Thibaud E; Polak M; Frances AM; Lespinasse J; Raingeard I; Servant N; Audran F; Paris F; Sultan C
    Reprod Biol Endocrinol; 2010 Mar; 8():28. PubMed ID: 20302644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SRY-calmodulin complex formation induces ectopic expression of ovarian cell markers in developing XY gonads.
    Sim H; Argentaro A; Czech DP; Bagheri-Fam S; Sinclair AH; Koopman P; Boizet-Bonhoure B; Poulat F; Harley VR
    Endocrinology; 2011 Jul; 152(7):2883-93. PubMed ID: 21558314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of five NR5A1 gene mutations found in patients with 46,XY disorders of sex development.
    Fabbri-Scallet H; de Mello MP; Guerra-Júnior G; Maciel-Guerra AT; de Andrade JGR; de Queiroz CMC; Monlleó IL; Struve D; Hiort O; Werner R
    Hum Mutat; 2018 Jan; 39(1):114-123. PubMed ID: 29027717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeoproteins Six1 and Six4 regulate male sex determination and mouse gonadal development.
    Fujimoto Y; Tanaka SS; Yamaguchi YL; Kobayashi H; Kuroki S; Tachibana M; Shinomura M; Kanai Y; Morohashi K; Kawakami K; Nishinakamura R
    Dev Cell; 2013 Aug; 26(4):416-30. PubMed ID: 23987514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency.
    Köhler B; Lin L; Ferraz-de-Souza B; Wieacker P; Heidemann P; Schröder V; Biebermann H; Schnabel D; Grüters A; Achermann JC
    Hum Mutat; 2008 Jan; 29(1):59-64. PubMed ID: 17694559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Mutation in the Critical P-Box Residue of Steroidogenic Factor-1 Presenting with XY Sex Reversal and Transient Adrenal Failure.
    Orekhova AS; Kalinchenko N; Morozov IA; Vasilyev EV; Rubtsov PM; Dedov II; Tiulpakov A
    Horm Res Paediatr; 2018; 89(6):450-454. PubMed ID: 29151085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9.
    Croft B; Ohnesorg T; Hewitt J; Bowles J; Quinn A; Tan J; Corbin V; Pelosi E; van den Bergen J; Sreenivasan R; Knarston I; Robevska G; Vu DC; Hutson J; Harley V; Ayers K; Koopman P; Sinclair A
    Nat Commun; 2018 Dec; 9(1):5319. PubMed ID: 30552336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.